Olsson CA - Search Results

1

The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer.

Nejat RJ, Katz AE, Olsson CA. Nejat RJ, et al. Among authors: olsson ca. Semin Urol Oncol. 1998 Feb;16(1):40-5. Semin Urol Oncol. 1998. PMID: 9508082 Review.

2

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

Gewanter RM, Katz AE, Olsson CA, Benson MC, Singh A, Schiff PB, Ennis RD. Gewanter RM, et al. Among authors: olsson ca. Urology. 2003 May;61(5):967-71. doi: 10.1016/s0090-4295(02)02581-5. Urology. 2003. PMID: 12736017

3

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Katz AE, et al. Among authors: olsson ca. Urology. 1994 Jun;43(6):765-75. doi: 10.1016/0090-4295(94)90132-5. Urology. 1994. PMID: 7515202

4

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.

Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, Katz AE. Cama C, et al. Among authors: olsson ca. J Urol. 1995 May;153(5):1373-8. J Urol. 1995. PMID: 7536252 Free article.

5

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE. Olsson CA, et al. J Urol. 1996 May;155(5):1557-62. J Urol. 1996. PMID: 8627821 Free article.

6

Molecular staging of genitourinary malignancies.

Katz AE, De Vries GM, Olsson CA, Benson MC, Swanton P, Ikeguchi EF, Buttyan R. Katz AE, et al. Among authors: olsson ca. Urology. 1996 Jun;47(6):948-58. doi: 10.1016/S0090-4295(96)00110-0. Urology. 1996. PMID: 8677601 Free article. Review. No abstract available.

7

The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer.

Olsson CA, De Vries GM, Benson MC, Raffo A, Buttyan R, Cama C, O'Toole K, Katz AE. Olsson CA, et al. Br J Urol. 1996 Mar;77(3):411-7. doi: 10.1046/j.1464-410x.1996.90616.x. Br J Urol. 1996. PMID: 8814848

8

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer.

Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, Olsson CA. Katz AE, et al. Among authors: olsson ca. Cancer. 1995 Apr 1;75(7):1642-8. doi: 10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1. Cancer. 1995. PMID: 8826922

9

The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy.

Katz AE, de Vries GM, Benson MC, Buttyan RE, O'Toole K, Rubin MA, Stifelman M, Olsson CA. Katz AE, et al. Among authors: olsson ca. Urol Clin North Am. 1996 Nov;23(4):541-9. doi: 10.1016/s0094-0143(05)70334-7. Urol Clin North Am. 1996. PMID: 8948409 Free article. Review.

10

Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay.

Cama C, Olsson CA, Buttyan R, de Vries GM, Wise GJ, Katz AE. Cama C, et al. Among authors: olsson ca. J Urol. 1997 May;157(5):1748-51. J Urol. 1997. PMID: 9112519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters